Podcasts about lectureship

During this presentation, Donald DiPette, MD, FACP, FAHA, on behalf Robert M. Carey, MD, reviews the role of the RAAS in normal blood pressure and salt and water homeostasis. In addition, Dr. DiPette discusses the role of the RAAS in the pathophysiology of cardiovascular disease, diabetes mellitus, and kidney disease, and he also details the pharmacologic inhibition/blockade of the RAAS.

his episode is brought to you by Faulkner University (www.faulkner.edu). Ben and Travis come to you live from Faulkner's Bible Lectureship prior to the Gambling debate on Thursday. You can watch the debate here: https://www.youtube.com/live/B_bP7lHyzK8 Links mentioned in this episode: Get our free ebook "28 Days of Focused Living" here: https://www.benandtravis.com https://www.facebook.com/groups/benandtravis Reframing Hope Book: https://www.benandtravis.com/books For extra content and material you can use for your family or ministry go to https://www.patreon.com/benandtravis Represent the show: https://www.benandtravis.com/store The Friday ReFresh: https://podcasts.apple.com/us/podcast/the-friday-refresh/id1611969995 Good Old Fashioned Dislike Podcast: https://podcasts.apple.com/us/podcast/good-old-fashioned-dislike/id1643163790 Co-Producers: Justin B., Doris C., Rhonda F., Scott K., Mary H. This podcast is hosted by ZenCast.fm

In 2016, the Australian government launched a program it said would make tracking welfare benefits easier. Instead, it falsely told hundreds of thousands of Australians they owed the government money, with some of those individuals taking their own lives as a result. Australia's robodebt tragedy is the focus of this episode of Stats+Stories with guests Noel Cressie and Dennis Trewin. Noel Cressie is Distinguished Professor at the University of Wollongong, Australia, and Director of its Centre for Environmental Informatics, which is a vibrant interdisciplinary group doing research in spatio-temporal statistics, satellite remote sensing, and broader fields of environmental science; he is also Adjunct Professor at the University of Missouri and Affiliate at NASA's Jet Propulsion Laboratory in the USA. Noel grew up in Western Australia, received a PhD from Princeton University, and shared a career between the US and Australia. He is author and co-author of four books, three of them on spatial and spatio-temporal statistics, and of more than 300 peer-reviewed publications. His recent research involves hunting for atmospheric-carbon-dioxide sources around the world and focusing on Antarctica's environmental future. He has won a number of awards, including the Fisher Award and Lectureship from the Committee of Presidents of Statistical Societies (COPSS), the Pitman Medal from the Statistical Society of Australia, the Barnett Award from the Royal Statistical Society, and the Matheron Award and Lecture from the International Association for Mathematical Geosciences. Noel is a Fellow of the Australian Academy of Science, of the Royal Society of New South Wales, and of a number of other learned societies. Dennis Trewin is a pioneer of social statistics that are leading to meaningful measurement of social capital in Australia. He was the head of the Australian Bureau of Statistics between 2000 and 2007, and held other senior appointments in Australia such as Electoral Commissioner and an Adjunct Professor at Swinburne University. Dennis is also a member of the Committee charged with responsibility for producing an independent report on the State of the Environment.

Would you be surprised if a wombat won a statistical achievement award? well our guest Noel Cressie is here to talk about the WOllongong Methodology for Bayesian Assimilation of Trace-gases and how it can impact the environmental landscape. Noel Cressie is Distinguished Professor at the University of Wollongong, Australia, and Director of its Centre for Environmental Informatics, which is a vibrant interdisciplinary group doing research in spatio-temporal statistics, satellite remote sensing, and broader fields of environmental science; he is also Adjunct Professor at the University of Missouri and Affiliate at NASA's Jet Propulsion Laboratory in the USA. Noel grew up in Western Australia, received a PhD from Princeton University, and shared a career between the US and Australia. He is author and co-author of four books, three of them on spatial and spatio-temporal statistics, and of more than 300 peer-reviewed publications. His recent research involves hunting for atmospheric-carbon-dioxide sources around the world and focusing on Antarctica's environmental future. He has won a number of awards, including the Fisher Award and Lectureship from the Committee of Presidents of Statistical Societies (COPSS), the Pitman Medal from the Statistical Society of Australia, the Barnett Award from the Royal Statistical Society, and the Matheron Award and Lecture from the International Association for Mathematical Geosciences. Noel is a Fellow of the Australian Academy of Science, of the Royal Society of New South Wales, and of a number of other learned societies.

Soil Management for Sustainable Agriculture Checking Soil Temperature Before Planting Corn Picking a Fruit Tree   00:01:05 – Soil Management for Sustainable Agriculture: Beginning today's show is Rattan Lal, K-State's Roscoe Ellis Jr. Lecturer, as he discusses sustainable agriculture and how soil management impacts food and climate security. Rattan Lal Roscoe Ellis, Jr. Lectureship   00:12:05 – Checking Soil Temperature Before Planting Corn: K-State farming systems specialist, Ignacio Ciampitti, continues the show as he reminds corn growers about the importance of soil temperature for planting and emergence. Mesonet - Soil Temperature Spring Planting in Kansas   00:23:05 – Picking a Fruit Tree: Rebecca McMahon, Extension Local Food Systems Program administrator, finishes the show as she covers the basics for selecting fruit tree varieties, such as apples, pears, peaches, cherries and plums.    Send comments, questions or requests for copies of past programs to ksrenews@ksu.edu.   Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Shelby Varner and distributed to radio stations throughout Kansas and as a daily podcast.   K‑State Research and Extension is a short name for the Kansas State University Agricultural Experiment Station and Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices, experiment fields, area Extension offices and regional research centers statewide. Its headquarters is on the K‑State campus in Manhattan

Host: Robert Hatfield  |  Released Thursday, January 25, 2024 This year’s theme for the Annual Bible Lectureship at Freed-Hardeman University is “Triumph of the Lamb: the Battle with Evil in Revelation.” Dr. Doug Burleson, professor of Bible at FHU and the director of the Annual Bible Lectureship, joins Robert this week to discuss the challenges […]

This episode is brought to you by the "Ministering to Youth Conference" on November 2-5 in Florence, Alabama on the campus of Heritage Christian University. Get more info at https://www.m2yconference.com/ This episode of brought to you by "Daisy's Place". Find out how you can support people in their darkest hour right here: www.daisys-place.org Ben and Travis setup in the Harris-Parker Building on the campus of Faulkner University during the 2023 Lectureships. The guys recap the Erupt Youth Rally and their time at the lectureships before discussing the October 25th debate. The guys are joined Matthew Morine as a suprise guest to talk about his ministry in Colorado. "Does the God of the Bible Exist" Debate with Kyle Butt and Michael Shermur: https://www.youtube.com/live/90PQQM4a75w?si=f5V3c3UfWsWIDQl2 Links mentioned in this episode: Get our free ebook "28 Days of Focused Living" here: https://www.benandtravis.com https://www.facebook.com/groups/benandtravis Reframing Hope Book: https://www.benandtravis.com/books For extra content and material you can use for your family or ministry go to https://www.patreon.com/benandtravis Represent the show: https://www.benandtravis.com/store The Friday ReFresh: https://podcasts.apple.com/us/podcast/the-friday-refresh/id1611969995 Good Old Fashioned Dislike Podcast: https://podcasts.apple.com/us/podcast/good-old-fashioned-dislike/id1643163790 Co-Producers: Justin B., Cayron M., Doris C., Rhonda F., Scott K., Mary H. This podcast is hosted by ZenCast.fm

Joining me on the podcast is Luke Dockery, Youth In Family Minister for the Cloverdale Church of Christ in Searcy, AR, and John David Alston, Youth Minister for the Kings Crossing Church of Christ in Corpus Christi, TX. Today we talk about some highlights of Harding University's Centennial Lectureship, which lectures we liked the most, and why we love going to lectureship.

This is a snippet of a Lecture at our National Convention! His name is Jordan Griffin! He is a graduate of Moorehouse and Vanderbilt! His next pursuit is a PH.D from Chicago Theological!

Dr David Maguire (Honorary Senior Research Associate, UCL, Institute of Education) Dr David Maguire has researched and managed projects for excluded groups across sectors that include housing, education, prison and the wider criminal justice system. In 2016 he was awarded D.Phil. (PhD) from the University of Oxford for research focusing on the interplay between masculinity, education, (un)employment, crime and imprisonment. After holding Lectureship positions in Criminal Justice, Criminology and Sociology, David took up a British Academy Postdoctoral Fellowship at UCL's Institute of Education that explored post prison transitions into employment and education. He has written and published on prison masculinities, and is the author of British Society of Criminology prize winning book:  Male, Failed, Jailed : Masculinities and "Revolving-Door" Imprisonment in the UK. He is currently the Director for the Prison Reform Trust's Building Futures project, a five-year programme for prisoners who are serving or have served 10 or more years in prison.

Dan and Mike talk with Dr Daniel Berge, New Testament professor at the Lutheran Brethren Seminary to get all the available details regarding the A.A Peterson Lectureship.

Dr Kamar Ameen-Ali narrates her blog written for Dementia Researcher. If you are looking to pursue a career in academia, it's not just about teaching and research. Kamar, a lecturer in biomedical science at Teesside University, shares her experience and insights on obtaining a permanent academic position. In her blog, she highlights the different routes to obtaining permanent positions, such as fellowships, and provides key advice on applying for lectureships. This is a must-read for anyone who wants to pursue a career in academia and understands the challenges and opportunities available in the field. Find the original text, and narration here on our website. https://www.dementiaresearcher.nihr.ac.uk/guest-blog-should-you-apply-for-a-lectureship/ -- Dr Kamar Ameen-Ali is a Lecturer in Biomedical Science at Teesside University & Affiliate Researcher at Glasgow University. In addition to teaching, Kamar is exploring how neuroinflammation following traumatic brain injury contributes to the progression of neurodegenerative diseases that lead to dementia. Having first pursued a career as an NHS Psychologist, Kamar went back to University in Durham to look at rodent behavioural tasks to completed her PhD, and then worked as a regional Programme Manager for NC3Rs. -- Enjoy listening? We're always looking for new bloggers, drop us a line. http://www.dementiaresearcher.nihr.ac.uk This podcast is brought to you in association with Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia, who we thank for their ongoing support.

Ask Your Mentor Podcast, from Dementia Researcher, in association with Alzheimer's Research UK (ARUK). Mentees interviewing their mentors, talking careers, lessons learned and what they've discovered, that could help you forge a successful career in dementia research. In this podcast Dr Melissa Salazar from University College London interviews Dr Steven Quinn, Senior Lecturer & Alzheimer's Research UK Fellow from University of York. Melissa is a Postdoctoral Research Fellow based in the UK Dementia Research Institute at University College London. She is a scientist with +10 years of research experience, who is specialised in sequencing methods and data analysis to study the genetics of Alzheimer's and Parkinson's disease. Steve is a Senior Lecturer & Alzheimer's Research UK Fellow at University of York. Steve obtained his MPhys in Physics from the University of St. Andrews and an MSc in Radiation, Oncology and Biology from the University of Oxford. After his PhD (St Andrews) and a postdoctoral position at the University of Glasgow, he took up a Lindemann Fellowship at the Massachusetts Institute of Technology (MIT) in the USA and in 2017, he was appointed to a Lectureship at the University of York and was awarded an Alzheimer's Research UK Fellowship in 2019. Steve is now a Senior Lecturer, and his group uses microscopy techniques to interrogate the structure, dynamics and function of single biomolecules implicated in dementia. Full biographies on all our guests and a transcript can be found on our website ⁠⁠https://www.dementiaresearcher.nihr.ac.uk⁠⁠ Find our more about Alzheimer's Research UK and how they support early career researchers on their website: ⁠⁠https://www.alzheimersresearchuk.org/research/for-researchers/ecr/supporting-your-career/⁠⁠ Like what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode – and if you prefer to listen rather than watch, you'll find an audio version of this podcast at ⁠https://podfollow.com/ask-your-mentor⁠ This podcast is brought to you by University College London / UCLH NIHR Biomedical Research Centre in association with Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia who we thank for their ongoing support. --- Send in a voice message: https://podcasters.spotify.com/pod/show/askyourmentor/message

In this special episode, listen to Dr. Ángel Cabrera, president of the Georgia Institute of Technology, give his address as the 19th speaker in Darlington's annual Class of 1953 Lectureship Series. Cabrera is the first native of Spain to serve as president of an American university. In his address, he shares wisdom from his life for students as they look forward to college and their future careers.Click here for complete show notes >>

Experiences of a Colorado Farm Boy that Led to Leading Mars Rover Missions Propagating for Genetically Identical New Plants   00:01:08  — Experiences of a Colorado Farm Boy that Led to Leading Mars Rover Missions, Part One: For 38 years the Roscoe Ellis, Jr. Lectureship has brought prominent scholars in soil science to Kansas State University in order to foster advancements in soil science through interactions with both students and faculty. This year Doug Ming traveled to K-State to share his experiences as a planetary scientist at NASA. During this two-part series, Doug shares insight on his life growing up as a Colorado farm boy, studying agronomy throughout college, and ultimately leading Mars rover missions over the course of two decades.   00:12:08  — Experiences of a Colorado Farm Boy that Led to Leading Mars Rover Missions, Part Two: We continue our conversation with Doug Ming, NASA planetary scientist, where he shares insight on how Mars' soils compare to those we know well here on Earth, his advice for students, and the potential for life on Mars.   00:23:09  — Propagating for Genetically Identical New Plants: We end today's show with Jason Griffin, directore of the John C. Pair Horticulture Center. He was the featured horticulturalist for February's K-State Garden Hour where he provided an overview of vegetative propagation - the process of making new plants that are genetically identical to your existing plants. Today, we pass along some of his tips for successful vegetative propagation.   K-State's Garden Hour programming   Send comments, questions, or requests for copies of past programs to ksrenews@ksu.edu. Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Samantha Bennett and distributed to radio stations throughout Kansas and as a daily podcast.   K‑State Research and Extension is a short name for the Kansas State University Agricultural Experiment Station and Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices, experiment fields, area Extension offices and regional research centers statewide. Its headquarters is on the K‑State campus in Manhattan.

Host: Robert Hatfield  |  Released Thursday, January 19, 2023 Go behind the scenes of the Annual Bible Lectureship at Freed-Hardeman University with lectureship director, Dr. Doug Burleson. Watch the Video Episode Resources [WEBSITE] 2023 FHU Lectureship: For Such a Time as This: Restoring God’s People in Ezra, Nehemiah, and Esther We want to hear from you! Email: […]

Host: Robert Hatfield  |  Released Thursday, January 19, 2023 Go behind the scenes of the Annual Bible Lectureship at Freed-Hardeman University with lectureship director, Dr. Doug Burleson. Watch the Video Episode Resources [WEBSITE] 2023 FHU Lectureship: For Such a Time as This: Restoring God’s People in Ezra, Nehemiah, and Esther We want to hear from you! Email: […]

Enduring CME will expire on 11/7/2024. The presentation is originating from Northeast Georgia Medical Center Gainesville. Objectives: - To understand the importance of communication in caring for patients - To discern the importance of communal storytelling for provider wellness - To promote empathy for our patients and the journeys they are on Disclosures: - There is no commercial support for this activity - The speakers have disclosed that there are no relevant personal or financial relationships Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Rev. Dr. Angela Sims is the author of "Lynched: The Power of Memory in a Culture of Terror."

We talk about the lecture in July 28-30. If you'd like to get a ticket, you can go to www.balancingthechristianlife.com/lectureIf you'd like to see the event website still in progress, you can go towww.balancingthechristianlife.com/lecturescheduleSupport the show (https://www.patreon.com/balancingthechristianlife)

Pentecostal Lectureship Series | Thursday | Chris E. W. Green by Northwest University

This week we give details about the lectureship we've been planning for late July. You can sign up for tickets at www.balancingthechristianlife.com/lectureIn this episode, Hal Hammons discusses the track he planned and Nathan Cox does the same.Support the show (https://www.patreon.com/balancingthechristianlife)

Jesuit priest and editor at large of America Magazine, Father James Martin, SJ, talks about his personal journey ministering to the LGBTQ community. For Martin, working with people on the margins, walking with the excluded, has always been part of his Jesuit life. Early in his career, he began writing about the LGBTQ community because he felt these were people in the church who had very few people to advocate for them. Then, after the 2016 nightclub massacre in Florida, he was deeply concerned about the lack of public support from Catholic bishops which inspired him to write a book, “Building a Bridge,” emphasizing the simple but life-changing tenets of respect, compassion, and sensitivity. Martin is the best-selling author of “Jesus: A Pilgrimage, The Jesuit Guide to (Almost) Everything” and “Learning to Pray.” He has written for many publications, including the New York Times and The Wall Street Journal, and he is a regular commentator in the national and international media. Series: "Burke Lectureship on Religion and Society" [Humanities] [Show ID: 37861]

Jesuit priest and editor at large of America Magazine, Father James Martin, SJ, talks about his personal journey ministering to the LGBTQ community. For Martin, working with people on the margins, walking with the excluded, has always been part of his Jesuit life. Early in his career, he began writing about the LGBTQ community because he felt these were people in the church who had very few people to advocate for them. Then, after the 2016 nightclub massacre in Florida, he was deeply concerned about the lack of public support from Catholic bishops which inspired him to write a book, “Building a Bridge,” emphasizing the simple but life-changing tenets of respect, compassion, and sensitivity. Martin is the best-selling author of “Jesus: A Pilgrimage, The Jesuit Guide to (Almost) Everything” and “Learning to Pray.” He has written for many publications, including the New York Times and The Wall Street Journal, and he is a regular commentator in the national and international media. Series: "Burke Lectureship on Religion and Society" [Humanities] [Show ID: 37861]

Jesuit priest and editor at large of America Magazine, Father James Martin, SJ, talks about his personal journey ministering to the LGBTQ community. For Martin, working with people on the margins, walking with the excluded, has always been part of his Jesuit life. Early in his career, he began writing about the LGBTQ community because he felt these were people in the church who had very few people to advocate for them. Then, after the 2016 nightclub massacre in Florida, he was deeply concerned about the lack of public support from Catholic bishops which inspired him to write a book, “Building a Bridge,” emphasizing the simple but life-changing tenets of respect, compassion, and sensitivity. Martin is the best-selling author of “Jesus: A Pilgrimage, The Jesuit Guide to (Almost) Everything” and “Learning to Pray.” He has written for many publications, including the New York Times and The Wall Street Journal, and he is a regular commentator in the national and international media. Series: "Burke Lectureship on Religion and Society" [Humanities] [Show ID: 37861]

Jesuit priest and editor at large of America Magazine, Father James Martin, SJ, talks about his personal journey ministering to the LGBTQ community. For Martin, working with people on the margins, walking with the excluded, has always been part of his Jesuit life. Early in his career, he began writing about the LGBTQ community because he felt these were people in the church who had very few people to advocate for them. Then, after the 2016 nightclub massacre in Florida, he was deeply concerned about the lack of public support from Catholic bishops which inspired him to write a book, “Building a Bridge,” emphasizing the simple but life-changing tenets of respect, compassion, and sensitivity. Martin is the best-selling author of “Jesus: A Pilgrimage, The Jesuit Guide to (Almost) Everything” and “Learning to Pray.” He has written for many publications, including the New York Times and The Wall Street Journal, and he is a regular commentator in the national and international media. Series: "Burke Lectureship on Religion and Society" [Humanities] [Show ID: 37861]

Jesuit priest and editor at large of America Magazine, Father James Martin, SJ, talks about his personal journey ministering to the LGBTQ community. For Martin, working with people on the margins, walking with the excluded, has always been part of his Jesuit life. Early in his career, he began writing about the LGBTQ community because he felt these were people in the church who had very few people to advocate for them. Then, after the 2016 nightclub massacre in Florida, he was deeply concerned about the lack of public support from Catholic bishops which inspired him to write a book, “Building a Bridge,” emphasizing the simple but life-changing tenets of respect, compassion, and sensitivity. Martin is the best-selling author of “Jesus: A Pilgrimage, The Jesuit Guide to (Almost) Everything” and “Learning to Pray.” He has written for many publications, including the New York Times and The Wall Street Journal, and he is a regular commentator in the national and international media. Series: "Burke Lectureship on Religion and Society" [Humanities] [Show ID: 37861]

Pentecostal Lectureship Series | Wednesday | Chris E.W. Green by Northwest University

Pentecostal Lectureship Series | Friday | Chris E. W. Green by Northwest University

Dr. Leighton Flowers welcomes an Oxford scholar, Dr. Ali Bonner, to talk about her book, "The Myth of Pelagianism," which can be found here: https://academic.oup.com/jts/article-abstract/71/1/374/5671779?redirectedFrom=fulltext Dr. Bonner earned her Ph.D. on the manuscript transmission of Pelagius' Letter to Demetrias. Subsequently, she was a British Academy Postdoctoral Fellow at Jesus College, Oxford, before being appointed to the Lectureship in Celtic History at Cambridge. Her research focuses on Pelagius and Faustus of Riez, two British authors of the fifth century who wrote in Latin, and she has published on St Patrick and Pelagius. She currently teaches Celtic history, that is, the history of the Brittonic speaking peoples and the Gaelic speaking peoples from AD 380 to 1170. To SUPPORT this broadcast please click here: https://soteriology101.com/support/   Is Calvinism all Leighton talks about? https://soteriology101.com/2017/09/22/is-calvinism-all-you-talk-about/   DOWNLOAD OUR APP: LINK FOR ANDROIDS: https://play.google.com/store/apps/de... LINK FOR APPLE: https://apps.apple.com/us/app/soterio...   Go to www.ridgemax.co for all you software developing needs! Show them some love for their support of Soteriology101!!!   To ORDER Dr. Flowers Curriculum “Tiptoeing Through Tulip” please click here: https://soteriology101.com/shop/   To listen to the audio only be sure to subscribe on iTunes, Stitcher, Google Play or one of the other podcast players found here: https://soteriology101.com/home/   For more about Traditionalism (or Provisionism) please visit www.soteriology101.com   Dr. Flowers' book, “The Potter's Promise” can be found here: https://www.amazon.com/Potters-Promis...   Dr. Flowers' book, “God's Provision for All” can be found here: https://www.amazon.com/Gods-Provision...   To engage with other believers cordially join our Facebook group: https://m.facebook.com/groups/1806702...   For updates and news follow us at:  www.facebook/Soteriology101   Or @soteriology101 on Twitter   Please SHARE on Facebook and Twitter and help spread the word!   To learn more about other ministries and teachings from Dr. Flowers go here: https://soteriology101.com/2017/09/22...   To become a Patreon supporter or make a one-time donation: https://soteriology101.com/support/

Host: Robert Hatfield  |  Released Thursday, January 20, 2022 Dr. Doug Burleson, associate professor of Bible and the director of the Annual Bible Lectureship at Freed-Hardeman University, stops by to discuss the 2022 Annual Bible Lectureship which is to take place February 6-10 on campus and online via live stream. Watch the Video Episode Resources […]

Host: Robert Hatfield  |  Released Thursday, January 20, 2022 Dr. Doug Burleson, associate professor of Bible and the director of the Annual Bible Lectureship at Freed-Hardeman University, stops by to discuss the 2022 Annual Bible Lectureship which is to take place February 6-10 on campus and online via live stream. Watch the Video Episode Resources […]

Dr. C. Stephen Evans, University Professor of Philosophy and Humanities at Baylor University gave the lecture titled "Thinking Radically and Biblically About Ethics"

“What kind of crossover things can you do to take (science) to them?” — Dr. Becky Smethurst   Making science more accessible to everyone. That's the mission of this week's guest on The Videocraft Show Presented By Video Husky.   Dr. Becky Smethurst is an astrophysicist and junior research fellow at the University of Oxford in England. Her studies focus primarily on galaxies, supermassive black holes, and their interactions with each other.    She's also found a second life educating viewers about science on YouTube. Dr. Becky makes videos with the aim of tackling our biggest questions about space, astronomy, and more in a way that's fun and easy to understand.    Dr. Becky authored and published her first book Space: 10 Things You Should Know with Penguin Random House in 2020. She's also won numerous awards, including most recently the Mary Somerville Medal and Prize from the Institute of Physics as well as the Caroline Herschel Prize for Lectureship in 2020. In this episode, Dr. Becky speaks with host Jon Santiago about: The importance of curiosity in her career as a scientist (and where it comes from) The years of practice it took for her to become comfortable with presenting ideas How creating videos as a YouTuber fits into her career as a scientist Her approach to reaching and engaging new audiences How she thinks about internet fame and responsibility as a creator with a platform And much more...   If you're a content creator, we know how time-consuming and tedious it is to edit your own videos. That's why Video Husky provides unlimited editing at a flat monthly rate. Just send us your footage plus instructions of what you want and you'll get the first draft of your video in 1-2 business days. Guaranteed.  Intrigued? Visit https://www.videohusky.com/pricing/.   Relevant Links Dr. Becky on YouTube Dr. Becky on Instagram Dr. Becky's book - "Space: The 10 Things You Should Know" Sixty Symbols YouTube channel DeepSkyVideos YouTube channel   Chapters (00:00) Intro (03:14) Start of conversation with Dr. Becky (04:03) Her relatability and how she makes being a scientist very normal (05:50) Logic and creativity in science and content creation (08:26) Being comfortable with uncertainty as a scientist (09:40) Her first memory of being fascinated with space (12:16) Where she got her curiosity growing up (14:34) How she started her career as an astrophysicist (17:44) Growing up in an all-girls school (19:14) How she is challenging scientist stereotypes (21:01) Her background in talking in front of an audience (28:00) How she started making content on YouTube (34:19) Her "Day in the life of an astrophysicist" video / Thinking of video ideas to expand her audience (37:46) Balancing her career and her YouTube channel (39:55) Her creative approach when making YouTube videos (44:20) Dealing with inappropriate comments on her YouTube videos (47:16) Conspiracy theories and false information on YouTube (50:18) What it's like to have microfame (53:21) Influencing vs. Inspiring (57:51) Advice Dr. Becky would give her younger self   Having trouble organizing ideas for your videos? Download a copy of our free script template by joining our email list: http://bit.ly/vc-script-template   Production Credits Producer: Nikki Vicente Editor: Ingrid Sarayba  Graphics: Paolo Lopez

Welcome to Episode 15 of The Darlington Podcast!  In this episode we feature https://www.darlingtonschool.org/Today/Details/5484608 (this year's speech from Darlington's 1953 Lectureship series) with https://www.dekalbcountyga.gov/chief-executive-officer/ceo-michael-l-thurmond (DeKalb County CEO Michael L. Thurmond). It was an incredible opportunity for our students to connect with someone who has had an outstanding career and has lived a life of service - and we hope that you will also be inspired by his message of service beyond self.  https://www.darlingtonschool.org/5594786 (Click here) for Michael L. Thurmond's bio and complete show notes.

Professor Richard Wiseman has been described as ‘…one of the most interesting and innovative experimental psychologists in the world today.’  His books have sold over 3 million copies and he presents keynote talks to organisations across the world, including The Swiss Economic Forum, Google and Amazon.He holds Britain’s only Professorship in the Public Understanding of Psychology at the University of Hertfordshire and is one of the most followed psychologists on Twitter.Street Magician to Psychology Professor Richard starts the podcast by talking about becoming completely hooked on magic at a young age. Whilst working in Covent Garden as a street magician,  Richard happened upon a magic book which described the similarities between magicians and psychologists. So began his interest in psychology. After completing his undergraduate degree at University College London (UCL), he went to Edinburgh University to work on a PhD looking at psychics and mediums as the team wanted someone with a background in the psychology of deception and magic. Upon completing that, Richard accepted a Lectureship at the University of Hertfordshire where he is now a professor. Public Understanding of PsychologyThrough work for radio and the BBC around identifying truth and lies, Richard talks about meeting two people that hugely impacted his career; Roger Highfield, who was the Science Editor at The Telegraph at the time and now is heavily involved in the Science Museum, and also Simon Singh, author of Fermat's Last Theorem. Putting ideas to paperRichard shares what he learnt from some time working in advertising, how to reframe and the importance of authenticity as a writer. In line with this, he talks about his book, The Luck Factor, looking at the psychology of luck. From this, he identified that small interventions can have big impact, which evolved into 59 seconds; think a little, change a lot. Behavioural ScienceRichard discusses how all the talks he gives are essentially about getting people to change, through simple interventions or 'opening the door' in a fun way. From these concepts, he wrote 'Rip it Up' about lifestyle change and during Covid-19, helped design a game where the more you kept away from people, the more lives you saved called 'Can you save the World?'.Richard talks about 'being expansive', working with Derren Brown who takes the audience on a journey from what seems a small idea through to what becomes a massive conclusion enthralling an entire audience. Takeaway Advice Richard leaves us with advice to find your passionate, be authentic and have a big vision. Don't be constrained by what others have done in the past and fundamentally, if you have a great idea, it will sell itself.   Contact Twitter @RichardWiseman CBC profile

Enduring CME will expire on 12/15/2022.Presenter: Andre Churchwell, MD; Vanderbilt University Medical CenterThe presentation is originating from Northeast Georgia Medical Center Gainesville.Objectives:- Explore how medical education and the health care system perpetuate disparities- Explain how provider bias and patient mistrust exacerbate health differences- Examine barriers to underrepresented minority recruitment and retention in the health care settingDisclosures:- There is no commercial support for this activity- The speakers have disclosed that there are no relevant personal or financial relationshipsAccreditation and Designation:The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.LinksClick here to complete the survey for CME credit.

Enduring CME will expire on 12/15/2022. The presentation is originating from Northeast Georgia Medical Center Gainesville. Objectives: - Explore how medical education and the health care system perpetuate disparities - Explain how provider bias and patient mistrust exacerbate health differences - Examine barriers to underrepresented minority recruitment and retention in the health care setting Disclosures: - There is no commercial support for this activity - The speakers have disclosed that there are no relevant personal or financial relationships Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Dr. Hayes interviews Dr. Lichter on his involvement with early breast preservation.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Welcome to JCO's Cancer Stories-- the Art of Oncology, brought to you by the ASCO podcast network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the role of cancer care. You can find all of the shows, including this one, at podcast.asco.org. Today, my guest on the podcast is Dr. Allen Lichter Dr. Lichter has a long and really storied history in the field of oncology over the last five decades. With his colleagues at the NCI, Drs. David Danforth and Mark Lippman, he was the radiation oncologist PI for one of the four studies that demonstrated that breast preserving therapy was as effective as mastectomy for newly diagnosed breast cancer. He more or less single-handedly started the Department of Radiation Oncology at the University of Michigan, now considered one of the top programs in the world. He is one of only three radiation oncologists to have been a dean at a major university in the United States, serving as such at the University of Michigan Medical School for eight years. And he is one of only three radiation oncologists who have been president of ASCO. The others are Sam Hellman, who I've interviewed previously, and our current president, Dr. Lori Pierce, who, by the way, is also from the University of Michigan. And his term was from 1997 to 1999. Dr. Lichter was born and raised in the Detroit area. He received his undergraduate and his medical degrees at the University of Michigan, after which he completed an internship at a community hospital-- St. Joseph's in Denver-- and then a residency in radiation oncology at the University of California, San Francisco. Following that, he joined the faculty at Johns Hopkins University, but after two short years there, he moved a few miles south to the National Cancer Institute in 1978, where he was head of the radiation therapy section of the radiation oncology branch. I believe you couldn't have been more than 32 or 33 years old, Allen, at the time. I counted up the years. He then moved back to Michigan to start the department here, which he chaired for eight years, and then became the dean for eight years. And then he went on to become the Chief Executive Officer of ASCO from 2006 to 2016. In spite of spending the last 20 years of his career as an administrator, Dr. Lichter has authored over 120 peer-reviewed papers. He was the co-editor of Clinical Oncology, one of the major textbooks on oncology, and has really been a leader, especially in radiation oncology, but in cancer in general in this country. I also want to add he was my boss for eight years when I first moved to University of Michigan, and during which time he was also my next door neighbor here in Ann Arbor. And I got to be his boss for one year-- if anybody could be Allen Lichter's boss-- from my term as ASCO president. Dr. Lichter, welcome to our program. It's great to be here, Dan. So a number of questions. I know, first of all, you grew up in Detroit and you went to Cass High School. And while this podcast is supposed to be about the history of oncology, having moved to Ann Arbor, I find the history of Cass High School awfully interesting. Has a number of famous alums, including Diana Ross, Lily Tomlin, Ellen Burstyn, Della Reese, David Alan Grier, Jack White, Alice Coltrane, and-- my guess is, Allen, you don't even know who Big Sean is, but he's a rapper. He's very famous right now for the younger generation. Any memories from your time there? Did you run into celebrities when you were there? It's quite a place to say you're from, I think. It's an interesting school, mostly a technical high school, located in downtown Detroit, but with a small college preparatory program that took students from all over the city with a competitive entrance exam. And I don't know what possessed me to get on the Second Avenue bus and ride downtown back and forth every day, but it was a fascinating experience. It takes you out of your normal peer group. I met young people-- friends-- from all walks of life, from all corners of the city. And it was a pretty rigorous education. I enjoyed it a great deal. And I played on the golf team. And it sounds to me like you knew you'd be a doctor then. Your father was a family practice doc in a small community just outside of Detroit. Was that true? Did you plan to go to medical school? Or did you have some epiphany when you were at high school? No, I never remember a single day not wanting to be a physician. My dad was a general practitioner and really instilled in my brother, and in me, a love of science and a love of medicine. My brother went on to be an ophthalmologist and was chair of the department at the University of Michigan for 34 years, President of the American Academy of Ophthalmology. So my dad and my brother set great examples for me, and into medicine I went. So I have to tell you, my father was a business man and was disappointed that I was in academics because he never understood why I wasn't generating income. My brother went to work for Eli Lilly. He was a doctor, too. And dad always thought he was doing something productive because he worked for Eli Lilly. So I don't know if your dad was disappointed you went to academics instead of family practice, but-- It was interesting. When I started my residency training, I was certainly confident that I would head into private practice and live a life much like my father did. And when I finished training, I decided I just needed a little more buffing up. I figured I'd go into academics for a couple of years, just to make sure I had a good grounding, and then go into private practice. I love the academic life and stayed there my whole career. I've been fond of asking previous interviewees-- why'd you choose oncology, and specifically radiation oncology, in your case? What led you to go into this path? Especially 40 years ago-- there wasn't a whole lot of oncology to go into. Well, you know, I was one of those medical students that loved virtually every rotation, and after that rotation I was going to become a fill in the blank. In my senior year of medical school, we were allowed to take an away elective, and I wanted to explore radiology as a potential field. My brother had a very good friend who was a radiation oncologist at the University of California, San Francisco, and the chance in the early 70s to go to San Francisco-- especially avoiding the Michigan winter-- was very compelling. So I signed up for the electives, and when I got there, I found that it was six weeks of diagnostic radiology and six weeks of radiation oncology. I hadn't expected that, but what the heck. So I did my six weeks of down in the basement looking at teaching sets, which was really quite inspirational. And I went into radiation oncology. And after my first day, I called my father and I said, I found what I'm going to do. I'm going into radiation oncology. It was instantly fascinating. I love the camaraderie in the department. I love the blend between the physical exams of patients, the treatment of cancer, the use of very high technology equipment and physics. It just struck me and I never wavered from that point on. So I've heard you talk about this-- and I'm 10 years behind you and even was true when I trained-- was that there wasn't a whole lot of science in radiation oncology back 40 years ago. And the field has evolved. And there are two things-- one you already hit on, which is it was combined with diagnostic radiology. And the second is it split away from diagnostic radiology to become its own field, and a lot of science. I've spoken with Saul Rosenberg and Sam Hellman and sort of asked them the same question. Give us just a background of the last 40 years of the evolution of radiation oncology because you had a lot to do with that. Well, of course, the field grew up, as you point out, inside the broad field of radiology. I always would tell my trainees that when Rankin discovered the X-ray, he forgot to discover the instruction manual. So there was a trial and error learning with this very useful technology, but very dangerous technology over a long period of time. For quite some period of time, you trained in general radiology. You had some time in diagnostic a little time in therapy, and you went out and could do both. But as I entered the field, it was becoming more and more difficult to learn radiation oncology in just the few weeks that they rotated in from their diagnostic duties. And I was one of the earliest group of trainees who trained in straight radiation oncology-- no diagnostic training, per se. And the field, as you say, split from diagnostic radiology. Had our own boards. I was amongst the earliest group to take the specialty board in radiation oncology. And the other thing that was true, certainly back in the late 60s and early 70s, is that so much of the field was experiential-- that is, people wrote papers like, you know, the last 100 patients with cancer of the lung that I treated. And this was valuable, but the need to do rigorous, well-controlled clinical trials was obvious to everyone inside the field. And so the field did become much more scientific. Never quite much as medical oncology, and part of that is because devices are treated differently at the FDA than drugs. Drugs you have to prove through scientific investigation that the agent is safe and effective. And then you can release it for patient use. For devices, you just have to prove that it basically doesn't kill anybody. And you can get an approval of a device and often get a billing code for the device. So the approval comes, and then you're supposed to do the science. Well, a lot of people, at that point, they're just too busy using the technology, then, to actually step back and do the science. And, of course, if you spent a lot of money for a piece of technology, to do the science to find out that wasn't a very wise investment is not in your self-interest. So our science lagged behind. I think it is certainly catching up, but it's still, in fact, in many cases, has a ways to go. I have enormous respect for our colleagues in the FDA on the devices side, and their hands are tied a bit. But I liken some of what they do to being like underwriter's laboratory. If you plug it in, it doesn't blow up, so they approve it. Yes. It's a little more than that, but you're right. And so much of the device approvals are based on a predicate of a similar device. And it goes from A to B to C and finally, you know, years down the road, the equipment and its use and its underlying structure is so different from the original device that was approved years ago that you rely on, at every step of the way, it really has-- there's been a lot of scrutiny about changing that, and I think over time it will change. You know, historically, it's interesting, by what you just said-- some of the first prospective randomized trials in all of medicine were radiation versus nil to the chest wall with breast cancer. To my knowledge, streptomycin versus nil for tuberculosis was the first, but then a whole series of radiation versus nil. But who would you give credit in the United States-- I would give part credit to you with the work you did with Drs. Lippman and Danforth. Probably one of the first randomized trials in radiation in this country. Well, you're correct that the first chest wall radiation trial started in Manchester, England in 1948. And at that point, doing randomized trials-- giving some patients the therapy and other patients observing or giving them a placebo-- that was not in widespread use in medicine. And over time, those types of trials began to become more common. I think in radiation oncology, our big advance was becoming part of the national co-operative group system, where many of the co-operative groups-- maybe all of them-- had a radiation oncology committee. And our studies were often integrated with surgical care or combined modality care with chemotherapy. And so we began a series of very important studies in breast cancer and lung cancer. The pediatric group did many, many trials that involved plus or minus radiation. I don't know that there's any specific person I'd give credit to, but it was the movement inside the field to join our other oncology colleagues in testing things rather than just doing observational work. You know, in that regard, let's circle back to your work at the NCI. That must've taken a fair amount of organizational and political skills to mount a breast preserving therapy, just at the NCI. The data that breast preserving therapy was safe was just beginning to be reported. The randomized trials in other places were ongoing. Give us some story there, how the three of you got that going and how you ran that. Well, of course, virtually everything at the NCI, from a clinical standpoint, is a clinical trial. Patients aren't treated there, just as going to their community hospital. You come to the NCI-- the travel is paid for, the care is paid for, et cetera, based on your agreement to enter into a study. At the time that I went to the NCI, the NSABP was doing their very large trial of lumpectomy versus mastectomy under Bernie Fisher's direction. My concerns were twofold. Number one-- this was being done at many, many centers around the country, and one could, I think, logically ask the question whether the quality of that care was going to be uniformly high enough to truly test breast preservation therapy. And secondly, I believed-- and many of us believed at the time-- that a boost to the tumor bed was quite important as part of having a low rate of local recurrence, and the NSABP study did not use the boost. They just treated the whole breast and stopped. And I said, you know, let's do a trial where it's done at a single institution, where the quality is going to be absolutely top notch, where we're going to use a boost and all of the technical tricks that we knew how to do this, just in case the NSABP study didn't come through. We'd have a backup. If both of them were negative, we could forget about lumpectomy and radiation, but if the NSABP was negative, we'd have this. As it turned out, the NSABP study, as you know, was positive, established for sure the equivalence of preservation therapy, and our study was sort of a little caboose at the end of the train. But that's OK. It confirmed what Ernie and colleagues confirmed very emphatically. Actually, there's an interesting article in the JCO written by Ian [INAUDIBLE] and his colleagues, about six months ago, that he preluded when he won the award your last year as CEO at ASCO. Was it your award? I can't remember. Yes. But anyway-- yeah. And in which, he designated the term I hadn't heard before of statistical fragility. And he made the point that many single prospective randomized trials are positive and the subsequent ones are not. And I give you and, of course, the Italians and the Brits also ran similar trials. It's nice to have four trials that all show the same thing. There's no statistical fragility in this observation. Yes, well, the NSABP trial was 1,800 patients. Our trial was about 240. We weren't going to change the world, but it was at least comforting to me that we had this trial coming along just in case. The other academic success that I give you credit for and would love to hear more about it is that you're interested in CT planning, which I think, really, was the forerunner, now, of stereotactic radiation and I would call precision radiation, as opposed to just blasting an organ and hoping you hit the cancer. And I think, really, a lot of that you brought when you started the department here. But how did you get interested in that? When I went to the NCI, my first day there, they took me on a tour of the department and we walked by a room with a locked door. I said, what's in there? And they said, oh that's our CT scanner, but we never use it. So I said, well, let me see it. And, you know, this was an EMI 5005. This was one of the early scanners. It was a body scanner, but it had a fairly small aperture. You could not get a lot of Americans into this machine. And I said, well, why don't we start scanning some patients. As long as-- does anybody know how to use this thing? Yes? OK, let's start scanning some patients. And it didn't take long to recognize that this was a machine that was almost tailor made to do radiation therapy planning. It gave you the contour of the patient's surface. It showed you the inside of the patient. It showed you the tumor in most settings. And remember, at that time we were facing radiotherapy treatment planning on plain x-rays taken on the simulator where, for example, when you treated the prostate, you never saw the prostate. You knew where the pubis was. You knew where the rectum was. You knew where the bladder was. And you knew the prostate had to be in there somewhere, but you never saw it. When we started to CT scan the pelvis in prostate cancer patients, there was the prostate in all its anatomic glory. And so we began to plan on this. And then it became pretty clear that if you took these slices and stacked them back up, like if you took a loaf of bread and it was laying out on the table as individual slices and stacked the slices back up, you could rebuild the three dimensional picture of the loaf. We decided that that might be a good thing to do with CT scans. And that's when I went to Michigan, and that's when we brought together some terrific physicists and brilliant programmers and spent a lot of money on a roomful of computers and began to do three dimensional reconstruction. And that led to a transformation in radiation therapy from a two dimensional specialty to a three dimensional specialty. And you could start firing at the tumor from cross sections from different directions. We didn't have to be in the actual plane, et cetera, et cetera, et cetera. And then we put a multi-leaf on the aperture, and so you could shape the field in real time. And it just went from there. So I have to tell you, when I was a first year fellow at Sidney Farber Cancer Institute, and I saw a patient who had received chest wall radiation-- not at our institution, by the way, not even in Massachusetts. She'd come from one of the other states. And basically, they had just stood her up in front of the machine and turned it on, as far as I could see. And the amount of normal tissue damage that she had suffered from this was incredible. And I called your friend, Jay Harris, and said, is this what we do here? He said, no way. Had me come down-- he showed me the beginnings of their CT planning and that sort of thing. I didn't know [INAUDIBLE] at the time, but then I learned later, mostly because of your doing. There were a number of outstanding institutions that were involved in this, and a lot of the inspiration for this came from some of the work that Sam Hellman was writing about, in terms of how we might better use imaging. So it was a team effort across the whole specialty. By the way, you bring up Dr. Hellman. We just lost Eli Glatstein in the last few months. I'll give you an opportunity to say some nice things about him. I know that you worked with him, and he was a giant in the field. The reason I was attracted down to the NCI is that this little short pudgy guy, Eli Glatstein, was recruited from Stanford by Vince Devita to come and run the radiation oncology branch. It was a pretty interesting time. There were five of us with Eli. All five of us became department chairs after our time at the NCI. He was just a phenomenal individual. He gave you a lot of rope. You could either hang yourself, or you could do the work you wanted to do. And we accomplished a lot. The other thing that I remember-- so I went to the NCI 1978. 1980, Eli said to me-- he handed me a piece of paper. I said, what's this? He says, it's an application form to join ASCO. You need to join ASCO. So I said, OK. That's not typically what radiation oncologists do, but I'll join. He sponsored me. And then he said, I'm going to see if I can't get you on a committee. And he did. I was on early Grants Award Committee. We handed out five or six young investigator grants. And I became chair of that committee. And then they said, well, you know, you did a nice job. We're going to put you on another committee, and way led to way. It was entirely because of Eli that I got introduced to ASCO and became such an important part of my life. He was a giant and will be sorely missed by all of us. And that's a perfect segue into my last question, which is changing gears completely, and that is your career at ASCO. Give us some ideas of what ASCO was like in the late 70s and how it has evolved-- principally, I mean, I know that's a whole hour long discussion, but I think you've had such a huge footprint in the society-- and what you saw changed, and the important changes. You know, ASCO was founded in 1964. There were no oncologists in 1964. There were doctors who were treating cancer-- some of them with surgery, some of them with radiation, some of them with these very early, highly toxic drugs. And so the society was formed. And it specifically says, when you read the early writings about this by the founders, that this was not a society of what they called chemotherapeutists. It was a society of physicians who wanted to treat cancer. They brought together all of the clinical specialties. I like to joke that the most interesting thing is that the medical oncologists forgot to found the American Society of Medical Oncology. They're the only specialty in medicine that doesn't have a specifically focused society just for them. They used ASCO, and to this day, it remains that way. And so I got involved. And the leaders of ASCO in the 70s and 80s and into the 90s, espousing how wonderful their multidisciplinary work was. And they used to have annual member meetings at the ASCO annual meeting. And the board would sit up on the dais, and the peanut gallery would ask questions. So I raised my hand, and I walked to the microphone, and I said, you know, it's great how you extol the multidisciplinary nature of the society. But I look at the dais, and I see the 12 members of the board of ASCO, and they're all medical oncologists. You are not practicing what you preach. And I sat down, and they mumbled a few things. And then the next thing I knew, darn it, they created board slots for a surgeon, a radiation oncologist, and a pediatric oncologist. And then they said, all right, big mouth, now that you held our feet to the fire, we're going to run you for the board. And I did get elected to the board, and then, eventually, got elected president. And then when they needed a CEO in 2006, they asked me if I was interested, and I interviewed for the job and then moved to Washington and then Alexandria and did that for 10 years. It was really-- you know, I say that I have been involved with two great organizations during my career-- the University of Michigan Medical School, and the American Society of Clinical Oncology. And to have the privilege of leading both of those organizations was just truly amazing. Well, there are many more things we could talk about, but for our listeners, you should know there's an Allen Lichter Visionary Leadership Award and Lectureship held at every annual meeting now. And for those of you who attend meetings at our headquarters in Alexandria, you'll notice you're sitting in the Allen S. Lichter conference center. Those weren't done by accident, by the way. They were done because of my guest today and all of the contributions he's made, not just oncology, frankly, but in my opinion, to medicine in general. As a dean, I know many of the things you've done, which we don't have time to get into. So on behalf of our listeners, and behalf of myself, and behalf of all the patients who have benefited through your work through the years, thanks so much, Allen. [INAUDIBLE] Dan, it was great being with you. Thanks for talking to me. Until next time, thank you for listening to this JCO's Cancer Stories-- The Art of Oncology podcast. If you enjoyed what you heard today, don't forget to give us a rating or review on Apple Podcasts, or wherever you listen. While you're there, be sure to subscribe so you never miss an episode. JCO's Cancer Stories-- The Art of Oncology podcast is just one of ASCO's many podcasts. You can find all the shows at podcast.asco.org.

The annual Pat Reif Memorial Lectureship was created in 2002 in honor of Patricia A. Reif, IHM, PhD. A scholar, educator, and activist, Reif taught philosophy and chaired the graduate department in religious studies at Immaculate Heart College. In 1984 she founded the MA program in feminist spirituality at Immaculate Heart College Center. Active in many social justice issues, including domestic abuse, poverty, immigration, welfare rights, and the anti-nuclear movement, Reif co-founded the Interfaith Hunger Coalition and the Southern California Interfaith Task Force on Central America (SCITCA).

In this podcast and the next, we will explore the lectureship recruitment process, gathering views from both members of recruitment panels, Prof Aaron Maule and Dr Karen McCutcheon, and recently appointed lecturers, Dr Donna Small and Dr Paul McVeigh. This first part focuses on generalities on lectureships and associated positions, the recruitment process and the profile of the ideal candidate. This discussion continues in episode #05.

In this podcast, we explore the lectureship recruitment process, gathering views from both members of recruitment panels, Prof Aaron Maule and Dr Karen McCutcheon, and recently appointed lecturers, Dr Donna Small and Dr Paul McVeigh. This second part focuses on Donna and Paul' profiles at the time they applied for their lectureships, application documents and interviews, as well as tips to get ready to apply. This discussion is the continuation from episode #04.

The ancient Buddhist sources have a great deal to say about what it means to be a biological man or woman, what it means to be gendered male and female, what kinds of desires and sexual practices are considered normative, and what kinds deviate. But this material is scattered throughout hundreds of different texts and is found in no single source. Drawing on decades of research into the classical Indian and Tibetan Buddhist texts - and on the extensive literature on ancient theories of "queerness" - Jose Cabezon traces the life of a man and woman from conception to death, in the process laying bare Buddhist assumptions about what it means to be normal and abnormal and why these issues were so important to ancient authors. Series: "Burke Lectureship on Religion and Society" [Humanities] [Show ID: 34403]

On this Marvelous Monday Dr. McKellar will be speaking with a special guest, Ms. Glynda Mayo-Hall, of Fairfax County, Northern Virginia.  Ms. Mayo-Hall is Chair of the National Women's Lectureship, which held an event this past weekend in Washington D.C.  Dr. McKellar will also answer questions from voters.  She has officially kicked off her campaign to unseat incumbent Louie Gohmert for US Congress in 2016 for Texas First District, and she would love to tell you where she stands on the issues voters care about!  Join Dr. McKellar on this, and every Marvelous Monday, right here on Blog Talk USA!